Safe Use of Ozempic: Guidelines for Effective Diabetes Management
Ozempic® (semaglutide) is a once-weekly GLP-1 receptor agonist injection produced by Novo Nordisk. It serves as an advanced medical solution for improving glycemic control, reducing cardiovascular risk, and most recently,...